Fund shareholders of Alnylam Pharmaceuticals Inc
ISIN US02043Q1076 · United States · LEI 529900S3ZI14OWRJII50
- Fund shareholders
- 760
- Of which ETFs
- 211 549 other funds
- Value held
- 24.8B $ 1.4B SEK · 14.6M €
- Share of capital
- 56.7 % of 133.8M shares on Jul 24, 2026
760 funds hold this company. This table lists the 756 that declare it in a regulatory filing. The other 4 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Growth-Income Fund AMERICAN FUNDS INSURANCE SERIES | 102,451 | 33.9M $ | 0.08 % | 0.08 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Blue Chip Growth Fund Fidelity Securities Fund | 100,081 | 31M $ | 0.18 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Empower T. Rowe Price Mid Cap Growth Fund EMPOWER FUNDS, INC. | 98,155 | 32.5M $ | 1.71 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Fidelity Enhanced Large Cap Growth ETF Fidelity Covington Trust | 97,612 | 32.3M $ | 0.69 % | 0.07 % | as of Mar 31, 2026 ↗ |
| JPMorgan Mid Cap Equity Fund JPMorgan Trust I | 97,191 | 32.2M $ | 0.58 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Touchstone Strategic Trust-Touchstone Mid Cap Growth Fund Touchstone Strategic Trust | 96,500 | 31.9M $ | 1.77 % | 0.07 % | as of Mar 31, 2026 ↗ |
| VANGUARD MID-CAP GROWTH FUND VANGUARD WHITEHALL FUNDS | 93,970 | 29.1M $ | 1.03 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Fidelity Growth Discovery Fund Fidelity Hastings Street Trust | 93,819 | 31M $ | 0.54 % | 0.07 % | as of Mar 31, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 90,332 | 29.9M $ | 0.07 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Capital Group Core Balanced ETF Capital Group Core Balanced ETF | 84,967 | 28.1M $ | 0.52 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity U.S. Equity Central Fund Fidelity Central Investment Portfolios LLC | 80,000 | 26.5M $ | 0.13 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 77,997 | 24.1M $ | 0.06 % | 0.06 % | as of Apr 30, 2026 ↗ |
| VIP Growth Opportunities Portfolio Variable Insurance Products Fund III | 77,751 | 25.7M $ | 0.61 % | 0.06 % | as of Mar 31, 2026 ↗ |
| AQR Long-Short Equity Fund AQR Funds | 77,579 | 25.7M $ | 0.32 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 77,290 | 25.7M $ | 0.11 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 76,684 | 25.5M $ | 0.07 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Nuveen Large Cap Growth Index Fund TIAA-CREF Funds | 76,174 | 23.6M $ | 0.13 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Large Cap Index Master Portfolio Master Investment Portfolio | 76,002 | 25.1M $ | 0.07 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Capital World Growth & Income Fund Capital World Growth & Income Fund | 75,608 | 25.2M $ | 0.02 % | 0.06 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 74,621 | 24.7M $ | 0.04 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fundamental All Cap Core Trust John Hancock Variable Insurance Trust | 73,947 | 24.5M $ | 1.07 % | 0.06 % | as of Mar 31, 2026 ↗ |
| EQ/Loomis Sayles Growth Portfolio EQ Advisors Trust | 71,426 | 23.6M $ | 3.09 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Neuberger Mid Cap Growth Fund NEUBERGER BERMAN EQUITY FUNDS | 70,433 | 23.4M $ | 1.18 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Capital Group Global Growth Equity ETF Capital Group Global Growth Equity ETF | 70,236 | 23.4M $ | 0.25 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Handelsbanken Hälsovård Tema Handelsbanken Fonder AB | 69,000 | 217.5M SEK | 0.98 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 68,871 | 21.3M $ | 0.06 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 68,488 | 21.2M $ | 0.05 % | 0.05 % | as of Apr 30, 2026 ↗ |
| JNL/Loomis Sayles Global Growth Fund JNL Series Trust | 67,394 | 22.3M $ | 2.86 % | 0.05 % | as of Mar 31, 2026 ↗ |
| NEOS Nasdaq-100(R) High Income ETF NEOS ETF Trust | 66,840 | 22.1M $ | 0.24 % | 0.05 % | as of Mar 31, 2026 ↗ |
| VANGUARD FTSE SOCIAL INDEX FUND VANGUARD WORLD FUND | 66,307 | 22.1M $ | 0.09 % | 0.05 % | as of Feb 28, 2026 ↗ |
| JNL/Mellon Nasdaq 100 Index Fund JNL Series Trust | 65,503 | 21.7M $ | 0.25 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 65,188 | 21.6M $ | 0.23 % | 0.05 % | as of Mar 31, 2026 ↗ |
| iShares U.S. Healthcare ETF iShares Trust | 65,114 | 20.2M $ | 0.72 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs ActiveBeta(R) U.S. Large Cap Equity ETF Goldman Sachs ETF Trust | 64,947 | 21.6M $ | 0.15 % | 0.05 % | as of Feb 28, 2026 ↗ |
| VANGUARD GLOBAL EQUITY FUND VANGUARD HORIZON FUNDS | 64,391 | 21.3M $ | 0.30 % | 0.05 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 63,824 | 21.1M $ | 0.07 % | 0.05 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Mid-Cap Growth ETF iShares Trust | 63,415 | 19.6M $ | 0.56 % | 0.05 % | as of Apr 30, 2026 ↗ |
| EQ/Large Cap Growth Managed Volatility Portfolio EQ Advisors Trust | 63,364 | 21M $ | 0.52 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Putnam Global Health Care Fund Putnam Global Health Care Fund | 62,800 | 20.9M $ | 1.32 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 60,901 | 18.8M $ | 0.66 % | 0.05 % | as of Apr 30, 2026 ↗ |
| VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS | 60,122 | 19.9M $ | 0.20 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 60,000 | 19.9M $ | 1.98 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Mid Cap Growth Stock Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 59,550 | 19.7M $ | 2.05 % | 0.04 % | as of Mar 31, 2026 ↗ |
| LVIP T. Rowe Price Structured Mid-Cap Growth Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 58,484 | 19.4M $ | 1.49 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Federated Hermes MDT Large Cap Growth Fund Federated Hermes MDT Series | 58,464 | 18.1M $ | 0.35 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Victory Nasdaq-100 Index Fund Victory Portfolios III | 56,941 | 17.6M $ | 0.20 % | 0.04 % | as of Apr 30, 2026 ↗ |
| VANGUARD TAX-MANAGED CAPITAL APPRECIATION FUND VANGUARD TAX-MANAGED FUNDS | 55,289 | 18.3M $ | 0.07 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Global X NASDAQ 100 Covered Call ETF GLOBAL X FUNDS | 54,832 | 17M $ | 0.20 % | 0.04 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Mid Cap Growth Portfolio Brighthouse Funds Trust I | 54,800 | 18.1M $ | 1.72 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Mid-Cap Growth Portfolio PACIFIC SELECT FUND | 54,604 | 18.1M $ | 2.36 % | 0.04 % | as of Mar 31, 2026 ↗ |
| JNL/Mellon Healthcare Sector Fund JNL Series Trust | 54,466 | 18M $ | 0.71 % | 0.04 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra QQQ ProShares Trust | 54,422 | 18.1M $ | 0.18 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 54,138 | 16.8M $ | 1.62 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Dodge & Cox Balanced Fund Dodge & Cox Funds | 53,400 | 17.7M $ | 0.12 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Six Circles Managed Equity Portfolio U.S. Unconstrained Fund SIX CIRCLES TRUST | 53,192 | 17.6M $ | 0.06 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Six Circles U.S. Unconstrained Equity Fund SIX CIRCLES TRUST | 51,706 | 17.1M $ | 0.06 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity Large Cap Stock Fund Fidelity Concord Street Trust | 50,648 | 15.7M $ | 0.15 % | 0.04 % | as of Apr 30, 2026 ↗ |
| EQ/JPMorgan Growth Stock Portfolio EQ Advisors Trust | 50,476 | 16.7M $ | 0.63 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Schwab Select Large Cap Growth Fund LAUDUS TRUST | 50,334 | 16.7M $ | 0.84 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Global Growth Fund AMERICAN FUNDS INSURANCE SERIES | 50,179 | 16.6M $ | 0.19 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Parnassus Mid Cap Growth Fund Parnassus Funds | 48,991 | 16.2M $ | 2.23 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity Fund Fidelity Hastings Street Trust | 48,700 | 16.1M $ | 0.19 % | 0.04 % | as of Mar 31, 2026 ↗ |
| iShares ESG Aware MSCI USA ETF iShares Trust | 46,857 | 15.6M $ | 0.10 % | 0.04 % | as of Feb 28, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 46,120 | 15.3M $ | 4.11 % | 0.03 % | as of Mar 31, 2026 ↗ |
| VOYA MIDCAP OPPORTUNITIES PORTFOLIO Voya Variable Products Trust | 46,028 | 15.2M $ | 1.77 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND | 45,992 | 15.2M $ | 0.29 % | 0.03 % | as of Mar 31, 2026 ↗ |
| MID-CAP INDEX PORTFOLIO VANGUARD VARIABLE INSURANCE FUNDS | 45,820 | 15.2M $ | 0.48 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Blue Chip Growth ETF Fidelity Covington Trust | 45,231 | 14M $ | 0.23 % | 0.03 % | as of Apr 30, 2026 ↗ |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO STATE STREET INSTITUTIONAL INVESTMENT TRUST | 45,080 | 14.9M $ | 0.57 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Natixis U.S. Equity Opportunities Fund Natixis Funds Trust I | 44,538 | 14.7M $ | 1.26 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Schwab 1000 Index Fund SCHWAB INVESTMENTS | 42,362 | 13.1M $ | 0.06 % | 0.03 % | as of Apr 30, 2026 ↗ |
| iShares MSCI ACWI ETF iShares Trust | 42,294 | 13.1M $ | 0.04 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 42,275 | 13.1M $ | 0.07 % | 0.03 % | as of Apr 30, 2026 ↗ |
| CIBC ATLAS MID CAP EQUITY FUND ADVISORS' INNER CIRCLE FUND | 41,015 | 12.7M $ | 1.89 % | 0.03 % | as of Apr 30, 2026 ↗ |
| AST Large-Cap Growth Portfolio Advanced Series Trust | 40,805 | 13.5M $ | 0.19 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Allspring Mid Cap Growth Fund ALLSPRING FUNDS TRUST | 40,790 | 13.5M $ | 2.36 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity New Millennium Fund Fidelity Mt. Vernon Street Trust | 40,000 | 13.3M $ | 0.25 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Capital Development Fund Fidelity Destiny Portfolios | 39,500 | 13.1M $ | 0.23 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 38,883 | 12.9M $ | 0.01 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 38,706 | 12M $ | 4.84 % | 0.03 % | as of Apr 30, 2026 ↗ |
| VY(R) T. ROWE PRICE DIVERSIFIED MID CAP GROWTH PORTFOLIO Voya Partners Inc | 38,412 | 12.7M $ | 1.49 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Franklin U.S. Mid Cap Multifactor Index ETF Franklin Templeton ETF Trust | 38,304 | 12.7M $ | 0.76 % | 0.03 % | as of Mar 31, 2026 ↗ |
| SA JPMorgan Mid-Cap Growth Portfolio SUNAMERICA SERIES TRUST | 38,076 | 11.8M $ | 1.77 % | 0.03 % | as of Apr 30, 2026 ↗ |
| VANGUARD GROWTH AND INCOME FUND VANGUARD QUANTITATIVE FUNDS | 37,960 | 12.6M $ | 0.08 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Victory Pioneer Disciplined Growth Fund Victory Portfolios IV | 37,676 | 12.5M $ | 0.58 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Fidelity Growth Strategies K6 Fund Fidelity Mt. Vernon Street Trust | 37,180 | 12.4M $ | 1.22 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Nuveen ESG Mid-Cap Growth ETF NuShares ETF Trust | 36,910 | 11.4M $ | 3.23 % | 0.03 % | as of Apr 30, 2026 ↗ |
| College Retirement Equities Fund - Global Equities Account College Retirement Equities Fund | 36,899 | 12.2M $ | 0.04 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Large Cap Index Fund Fidelity Concord Street Trust | 36,815 | 11.4M $ | 0.07 % | 0.03 % | as of Apr 30, 2026 ↗ |
| LVIP Global Equity Managed Volatility Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 36,777 | 12.2M $ | 1.41 % | 0.03 % | as of Mar 31, 2026 ↗ |
| LVIP American Century Ultra(R) Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 35,400 | 11.7M $ | 1.03 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Direxion NASDAQ-100 Equal Weighted Index Shares Direxion Shares ETF Trust | 35,072 | 10.9M $ | 0.89 % | 0.03 % | as of Apr 30, 2026 ↗ |
| iShares Russell 3000 ETF iShares Trust | 34,344 | 11.4M $ | 0.07 % | 0.03 % | as of Mar 31, 2026 ↗ |
| VOYA MIDCAP OPPORTUNITIES FUND Voya Equity Trust | 33,966 | 11.3M $ | 1.74 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Dimensional US High Profitability ETF Dimensional ETF Trust | 32,980 | 10.2M $ | 0.09 % | 0.02 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 32,630 | 10.8M $ | 1.63 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Global Index Criteria Handelsbanken Fonder AB | 32,085 | 101.1M SEK | 0.07 % | 0.02 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 31,371 | 10.4M $ | 0.01 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Victory 500 Index Fund Victory Portfolios III | 31,181 | 9.7M $ | 0.06 % | 0.02 % | as of Apr 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 30,539 | 10.2M $ | 0.11 % | 0.02 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 5.52 % | as of Apr 30, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 4.84 % | as of Apr 30, 2026 ↗ |
| Nestyield Dynamic Income ETF Tidal Trust III | 4.66 % | as of Feb 28, 2026 ↗ |
| NestYield Visionary ETF Tidal Trust III | 4.62 % | as of Feb 28, 2026 ↗ |
| Horizon Kinetics Medical ETF Listed Funds Trust | 4.14 % | as of Mar 31, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 4.11 % | as of Mar 31, 2026 ↗ |
| Nestyield Total Return Guard ETF Tidal Trust III | 4.06 % | as of Feb 28, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 3.99 % | as of Mar 31, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 3.99 % | as of Dec 31, 2025 ↗ |
| VANGUARD BAILLIE GIFFORD GLOBAL POSITIVE IMPACT STOCK FUND VANGUARD VALLEY FORGE FUNDS | 3.46 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 696 | +10 | 75,428,168 | +1.0 % |
| 2026Q1 | 686 | +34 | 74,668,226 | +1.3 % |
| 2025Q4 | 652 | +34 | 73,684,788 | -2.6 % |
| 2025Q3 | 618 | -6 | 75,686,877 | +2.2 % |
| 2025Q2 | 624 | +46 | 74,063,375 | -0.1 % |
| 2025Q1 | 578 | -8 | 74,152,711 | -1.2 % |
| 2024Q4 | 586 | +51 | 75,034,343 | +9.1 % |
| 2024Q3 | 535 | +19 | 68,756,140 | +5.3 % |
| 2024Q2 | 516 | -5 | 65,297,179 | +1.9 % |
| 2024Q1 | 521 | -7 | 64,072,072 | -8.1 % |
| 2023Q4 | 528 | 69,739,098 |
Institutional managers
775 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 14,579,166 | 4.8B $ | as of Mar 31, 2026 |
| Capital World Investors | 10,802,348 | 3.6B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 10,444,908 | 3.5B $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 9,471,181 | 3.1B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 6,323,752 | 2B $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 5,193,324 | 1.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 3,322,698 | 1.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,660,385 | 884.6M $ | as of Mar 31, 2026 |
| BAILLIE GIFFORD & CO | 2,493,866 | 825.1M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,992,577 | 659.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,935,925 | 640.5M $ | as of Mar 31, 2026 |
| Dodge & Cox | 1,929,253 | 638.3M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 1,802,363 | 596.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,432,748 | 474.1K $ | as of Mar 31, 2026 |
| Clearbridge Investments, LLC | 1,356,036 | 448.7M $ | as of Mar 31, 2026 |
| Orbis Allan Gray Ltd | 1,334,825 | 441.7M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,291,726 | 427.4M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 1,099,318 | 363.7M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,059,062 | 350.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,002,681 | 331.8M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 966,912 | 319.9M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 934,881 | 309.3M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 913,104 | 297.9M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 858,120 | 283.9M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 838,187 | 277.3M $ | as of Mar 31, 2026 |
Declared shareholders of Alnylam Pharmaceuticals Inc
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 11.00 % | 14,640,525 | as of Mar 31, 2026 · SCHEDULE 13G |
| Capital World Investors | 8.20 % | 10,916,799 | as of Mar 31, 2026 · SCHEDULE 13G |
| Capital Research Global Investors | 7.10 % | 9,471,181 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 5.35 % | 7,104,536 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Alnylam Pharmaceuticals Inc
33 funds declare 42 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Alnylam Pharmaceuticals Inc". https://titelia.com/en/stocks/alnylam-pharmaceuticals-inc-US02043Q1076